Silva Francisco

Silva Francisco is listed in filings as VP of Research and Development at BioRestorative Therapies, Inc.. This profile follows SEC Form 4 activity through Oct 20, 2025, including 3 public disclosures. Recent filings connect the profile to BioRestorative Therapies, Inc. (BRTX). The current snapshot covers public activity from Feb 19, 2025 to Oct 20, 2025. Reported amounts are shown as $1.9M to $18.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.